Eyelead SCK-1 Sensor Cleaning Kit for Nikon, Canon, Pentax, Olympus Camera (Assorted Colours)

Product Information

Patients with DME will be treated with one injection per month for the first five consecutive doses followed by one injection every two months thereafter. Some of these may be serious and include blindness , a serious infection or inflammation inside the eye (endophthalmitis), detachment, tear or bleeding of the light-sensitive layer at the back of the eye (retinal detachment or tear), clouding of the lens (cataract), bleeding in the eye (vitreous haemorrhage), detachment of the gel-like substance inside the eye from the retina (vitreous detachment) and increase of pressure inside the eye , see section 2. The solution should be inspected visually for any foreign particulate matter and/or discolouration or any variation in physical appearance prior to administration.

Eyelead με polarized φακούς κατηγορίας 3 εξαιτίας του αποκλεισμού της διέλευσης των κατά 90 μοιρών οριζόντια πολωμένων ακτίνων του φωτός προς το μάτι, έχουν την ικανότητα να εμποδίζουν την αντανάκλαση του έντονου φωτός (ποσοστό απορρόφησης 82-92%) και να προσφέρουν στον χρήστη βελτιωμένη όραση. This medicine contains less than 1 mmol sodium (23 mg) per dosage unit, that is to say essentially ’sodium-free’.To remove the syringe cap, hold the syringe in one hand while using the other hand to grasp the syringe cap with the thumb and fore finger.

Eylea should not be used during pregnancy unless the potential benefit outweighs the potential risk to the unborn child. To deter the introduction of air, ensure the bevel of the filter needle is submerged into the liquid.or detachment of one of the layers at the back of the eye (retinal detachment or tear, and retinal pigment epithelial detachment or tear), in which case Eylea must be given with caution. Push the filter needle into the centre of the vial stopper until the needle is completely inserted into the vial and the tip touches the bottom or bottom edge of the vial. Aflibercept, the active substance in Eylea, blocks the activity of a group of factors, known as Vascular Endothelial Growth Factor A (VEGF-A) and Placental Growth Factor (PlGF).